Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Conticello

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Leukemia Research|November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzleConcetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.
Cancers|March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 InfectionAlessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
Acta Haematologica|August 22, 2008
Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemiaConcetta Conticello, Luana Adamo, Luisa Vicari, et al.
Expert Review of Molecular Diagnostics|May 1, 2018
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapyAlessandra Romano, Nunziatina Laura Parrinello, Piera La Cava, et al.
Oncotarget|March 12, 2016
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)Cesarina Giallongo, Daniele Tibullo, Nunziatina L Parrinello, et al.
International Journal of Cancer|February 11, 2012
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignanciesConcetta Conticello, Daniela Martinetti, Luana Adamo, et al.
Leukemia Research|August 3, 2010
NF-κB localization in multiple myeloma plasma cells and mesenchymal cellsConcetta Conticello, Raffaella Giuffrida, Luana Adamo, et al.
Journal of Clinical Medicine|October 19, 2019
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma PatientsMarina Silvia Parisi, Salvatore Leotta, Alessandra Romano, et al.
Cell Death & Disease|October 30, 2019
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Cell Death & Disease|September 22, 2019
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Leukemia Research|November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzleConcetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.
Cancers|March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 InfectionAlessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
Acta Haematologica|August 22, 2008
Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemiaConcetta Conticello, Luana Adamo, Luisa Vicari, et al.
Expert Review of Molecular Diagnostics|May 1, 2018
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapyAlessandra Romano, Nunziatina Laura Parrinello, Piera La Cava, et al.
Oncotarget|March 12, 2016
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)Cesarina Giallongo, Daniele Tibullo, Nunziatina L Parrinello, et al.
International Journal of Cancer|February 11, 2012
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignanciesConcetta Conticello, Daniela Martinetti, Luana Adamo, et al.
Leukemia Research|August 3, 2010
NF-κB localization in multiple myeloma plasma cells and mesenchymal cellsConcetta Conticello, Raffaella Giuffrida, Luana Adamo, et al.
Journal of Clinical Medicine|October 19, 2019
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma PatientsMarina Silvia Parisi, Salvatore Leotta, Alessandra Romano, et al.
Cell Death & Disease|October 30, 2019
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Cell Death & Disease|September 22, 2019
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myelomaCesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Pageof 10